NCT03730428View on ClinicalTrials.gov

Everolimus Related Pneumonitis in MBC

CompletedOBSERVATIONAL
Enrollment

86

Participants

Timeline

Start Date

July 15, 2017

Primary Completion Date

May 15, 2020

Study Completion Date

June 15, 2020

Conditions
EverolimusPneumonitis
Trial Locations (1)

200032

Fudan University Shanghai Cancer Center, Shanghai

All Listed Sponsors
lead

Fudan University

OTHER

NCT03730428 - Everolimus Related Pneumonitis in MBC | Biotech Hunter | Biotech Hunter